TRS31 Antibody

What is TRS31 and how does it relate to TRAPPC5?

TRS31 and TRAPPC5 (trafficking protein particle complex 5) are two names for the same 181 amino acid protein that belongs to the TRAPP small subunits family and the BET3 subfamily. This protein is encoded by a gene that maps to human chromosome 19p13.2 and serves as a component of the multisubunit TRAPP tethering complex. TRAPPC5 is evolutionarily conserved across species and plays crucial roles in protein binding, vesicle-mediated transport, and nucleotide exchange stimulation . The protein's nomenclature can sometimes cause confusion in literature searches, so researchers should search for both terms when conducting comprehensive literature reviews.

What cellular functions does TRS31/TRAPPC5 perform?

TRS31/TRAPPC5 serves multiple critical cellular functions as part of the TRAPP complexes:

• It performs guanine nucleotide exchanger factor (GEF) functions both in vitro and in vivo

• It localizes primarily to the Golgi apparatus

• It is essential for endoplasmic reticulum (ER)-to-Golgi and intra-Golgi vesicle trafficking in yeast

• In mammals, it participates in additional transport events including post-Golgi trafficking

• As part of the TRAPPII complex, it serves as a GEF for Rab18 and, together with COPI, regulates Rab18 recruitment onto lipid droplet surfaces

Understanding these functions is critical for designing experiments that investigate membrane trafficking pathways and their regulation.

What are the different TRAPP complexes and how is TRS31/TRAPPC5 distributed among them?

The TRAPP complexes are multisubunit tethering complexes that act as guanine nucleotide exchange factors (GEFs). There are three main TRAPP complexes identified:

• TRAPPI: Contains common core subunits including TRAPPC3 and TRAPPC2

• TRAPPII: Contains common core subunits plus TRAPPC9, TRAPPC10, and enriched TRAPPC6B

• TRAPPIII: Contains common core subunits plus TRAPPC8 and TRAPPC6A

TRS31/TRAPPC5 is a component of the TRAPPII complex. This complex specifically activates Rab proteins including Rab1 and Rab18, but not Rab2, as demonstrated through nucleotide exchange assays . TRAPPIII shares six subunits with TRAPPI and TRAPPII, functioning as a Ypt1 guanine nucleotide exchange factor (GEF) .

What criteria should researchers use when selecting a TRS31/TRAPPC5 antibody?

When selecting a TRS31/TRAPPC5 antibody for research applications, consider these key criteria:

• Specificity: Verify the antibody recognizes TRAPPC5 specifically without cross-reactivity to other TRAPP components

• Application compatibility: Ensure the antibody is validated for your intended applications (Western blot, immunoprecipitation, immunocytochemistry, etc.)

• Species reactivity: Confirm reactivity with your experimental model species

• Recognition region: Consider whether the antibody targets a conserved or variable region based on your research goals

• Validation data: Review literature and manufacturer data showing successful use in your intended applications

Commercial antibodies may list specific aliases including TRS31, TRAPPC5, and 4021401A16Rik (mouse) or RGD1563971 (rat), which is important to note when searching antibody databases .

How can researchers validate the specificity of a TRS31/TRAPPC5 antibody?

Validating antibody specificity is critical for ensuring experimental reliability. For TRS31/TRAPPC5 antibodies, consider these validation approaches:

• Positive controls: Use cell lines or tissues known to express TRS31/TRAPPC5

• Knockout/knockdown validation: Compare antibody reactivity between wild-type and TRAPPC5-depleted samples

• Recombinant protein detection: Test antibody against purified recombinant TRAPPC5

• Peptide competition: Pre-incubate antibody with blocking peptide to confirm specific binding

• Orthogonal detection methods: Compare results with different antibodies or mRNA expression data

For immunoprecipitation experiments, researchers can confirm specificity by examining co-precipitation of known TRAPP complex partners such as TRAPPC3, TRAPPC2, TRAPPC10, or TRAPPC6B using Western blot analysis .

What is the recommended protocol for immunoprecipitation of TRS31/TRAPPC5-containing complexes?

For successful immunoprecipitation of TRS31/TRAPPC5-containing complexes, researchers can follow this optimized protocol based on published methods:

• Cell lysis: Harvest cells and lyse with buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40, and protease inhibitor cocktails

• Lysate clarification: Centrifuge at 12,000g for 30 minutes at 4°C

• Antibody incubation: Incubate supernatants with 1 μg of TRS31/TRAPPC5 antibody or non-specific IgG (control) at 4°C overnight

• Immunoprecipitation: Capture antibody-protein complexes using protein A/G beads

• Washing: Wash immunoprecipitates five times with lysis buffer

• Elution: Either resuspend in PBS for functional assays or elute by boiling in 2× SDS loading buffer for immunoblot analysis

This protocol has been demonstrated to successfully isolate TRAPP complexes while maintaining their functional activity for downstream applications like nucleotide exchange assays.

How can researchers investigate the GEF activity of TRS31/TRAPPC5-containing complexes?

To investigate the guanine nucleotide exchange factor (GEF) activity of TRS31/TRAPPC5-containing complexes such as TRAPPII, researchers can employ these methodological approaches:

• Nucleotide exchange assay using radioactive GDP release:

  • Pre-load GST-tagged Rab proteins (e.g., Rab18, Rab1, Rab2) with [³H]GDP

  • Add immunoprecipitated TRAPP complexes to the reaction

  • Monitor the reduction in radiolabel signal when captured on nitrocellulose filters

  • Include TRAPPIII as a negative control and known GEFs (e.g., Rab3GAP) as positive controls

• GTP uptake assay:

  • Pre-load GST-tagged Rab proteins with non-radioactive GDP

  • Add immunoprecipitated TRAPP complexes

  • Monitor uptake of [³⁵S]GTPγS in a time-dependent manner

  • Analyze results to determine which Rab proteins show exchange activity with which TRAPP complexes

These complementary approaches provide robust evidence of GEF activity and specificity.

What approaches can be used to study TRS31/TRAPPC5 function in model organisms?

Studying TRS31/TRAPPC5 function across model organisms presents unique challenges and opportunities:

What are common technical challenges when working with TRS31/TRAPPC5 antibodies?

Researchers frequently encounter these challenges when working with TRS31/TRAPPC5 antibodies:

• Cross-reactivity with other TRAPP components: Given the high conservation and shared domains within TRAPP complexes, antibodies may cross-react with related proteins. Validation using knockout controls is essential.

• Low abundance protein detection: TRS31/TRAPPC5 may be expressed at relatively low levels in some cell types, requiring optimized lysis and detection methods. Consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity.

• Complex stability during isolation: TRAPP complexes may dissociate during harsh lysis or immunoprecipitation conditions. Use gentle lysis buffers with 0.1% NP-40 rather than stronger detergents to maintain complex integrity .

• Antibody lot variability: Commercial antibodies may show lot-to-lot variation. Validate each new lot against previously successful lots before use in critical experiments.

How can researchers distinguish between different TRAPP complexes in experimental settings?

Distinguishing between different TRAPP complexes is critical for functional studies. Researchers can use these approaches:

• Complex-specific immunoprecipitation:

  • Use antibodies against specific subunits: TRAPPC9 for TRAPPII and TRAPPC12 for TRAPPIII

  • Validate complex composition by immunoblotting for complex-specific components:

    • TRAPPII: TRAPPC10, enriched TRAPPC6B

    • TRAPPIII: TRAPPC8, TRAPPC6A

    • Common subunits: TRAPPC3, TRAPPC2

• Functional assays:

  • GEF activity toward specific Rab proteins: TRAPPII shows activity for Rab1 and Rab18, while TRAPPIII does not

  • Cellular localization by immunofluorescence

  • Phenotypic assays based on known functions of specific complexes

• Size-based separation:

  • Use gel filtration chromatography to separate complexes based on size

  • Analyze fractions by immunoblotting for complex-specific components

How can TRS31/TRAPPC5 antibodies be used in vesicular trafficking research?

TRS31/TRAPPC5 antibodies serve as valuable tools in vesicular trafficking research through these applications:

• Colocalization studies: Using immunofluorescence microscopy to detect TRS31/TRAPPC5 colocalization with markers of the Golgi apparatus, ER, or vesicular intermediates

• Trafficking pathway disruption analysis: Monitoring changes in TRS31/TRAPPC5 localization or complex formation following treatment with trafficking inhibitors (Brefeldin A, nocodazole, etc.)

• Cargo trafficking assays: Examining how TRS31/TRAPPC5 depletion affects the trafficking of model cargo proteins between cellular compartments

• GEF activity correlations: Correlating TRS31/TRAPPC5 complex formation with Rab protein activation states in different trafficking conditions

• Interaction partner identification: Using TRS31/TRAPPC5 antibodies for immunoprecipitation followed by mass spectrometry to identify novel trafficking-related interaction partners

What are emerging research directions involving TRS31/TRAPPC5?

Several emerging research directions involve TRS31/TRAPPC5:

• Rational antibody design for therapeutic applications: Recent advances in developing stimulus-selective monoclonal antibodies for previously undruggable targets may provide new approaches to targeting TRAPP complexes for therapeutic purposes .

• Large-scale antibody repertoire analysis: The development of databases containing billions of antibody sequences provides new opportunities for identifying antibodies with specific properties against targets like TRS31/TRAPPC5 .

• Disease associations: Growing evidence links TRAPP complex mutations to rare disorders, suggesting potential roles for TRS31/TRAPPC5 in disease pathogenesis that merit further investigation .

• Lipid droplet regulation: The role of TRAPPII (containing TRS31/TRAPPC5) in regulating Rab18 recruitment to lipid droplets opens new research avenues in lipid metabolism and storage diseases .

• Post-Golgi trafficking: Beyond its established role in ER-to-Golgi trafficking, exploring TRS31/TRAPPC5's functions in post-Golgi transport events in mammals represents an expanding research direction .